期刊
GASTROENTEROLOGY
卷 147, 期 4, 页码 765-U110出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2014.07.018
关键词
Apoptosis; Necrosis; Necroptosis; Necrosome; DAMP; Viral Hepatitis; NASH; Clinical Trial; Hepatocellular Carcinoma; Alcoholic Liver Disease; DILI; Caspases; RIP3; RIP Kinases
资金
- German Cancer Aid (Deutsche Krebshilfe) [110043]
- German Research Foundation [SFB-TRR57/P06]
- ERC [ERC-2007-Stg/208237-Luedde-Med3-Aachen]
- EMBO Young Investigator Program
- Ernst Jung Foundation Hamburg
- medical faculty of RWTH Aachen
- [5R01DK067215]
- [5R01AA014428]
- [5P30DK0485]
- [1U01AA021912]
- [5R01AA020211]
- [5U54CA163111]
Hepatocellular death is present in almost all types of human liver disease and is used as a sensitive parameter for the detection of acute and chronic liver disease of viral, toxic, metabolic, or autoimmune origin. Clinical data and animal models suggest that hepatocyte death is the key trigger of liver disease progression, manifested by the subsequent development of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Modes of hepatocellular death differ substantially between liver diseases. Different modes of cell death such as apoptosis, necrosis, and necroptosis trigger specific cell death responses and promote progression of liver disease through distinct mechanisms. In this review, we first discuss molecular mechanisms by which different modes of cell death, damage-associated molecular patterns, and specific cell death responses contribute to the development of liver disease. We then review the clinical relevance of cell death, focusing on biomarkers; the contribution of cell death to drug-induced, viral, and fatty liver disease and liver cancer; and evidence for cell death pathways as therapeutic targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据